Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
12219 | 859 | 32.9 | 57% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
82 | 26468 | TUBERCULOSIS//INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE//MYCOBACTERIUM TUBERCULOSIS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ISONIAZID | Author keyword | 20 | 13% | 17% | 146 |
2 | DRUG REASSESSMENT | Address | 14 | 100% | 1% | 7 |
3 | DRUG INDUCED HEPATOTOXICITY | Author keyword | 7 | 32% | 2% | 18 |
4 | ATDH | Author keyword | 6 | 100% | 0% | 4 |
5 | TREATMENT OF LATENT TUBERCULOSIS INFECTION | Author keyword | 6 | 100% | 0% | 4 |
6 | LATENT TUBERCULOSIS INFECTION | Author keyword | 5 | 13% | 4% | 38 |
7 | CHARLES P FELTON TB | Address | 5 | 50% | 1% | 7 |
8 | ARGININOSUCCINIC ACID LYASE | Author keyword | 4 | 75% | 0% | 3 |
9 | ACETYLHYDRAZINE | Author keyword | 4 | 56% | 1% | 5 |
10 | ANTITUBERCULOSIS DRUGS | Author keyword | 4 | 22% | 2% | 16 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | N ACETYLTRANSFERASE 2 GENE | 28 | 81% | 2% | 17 |
2 | CYTOCHROME P450 2E1 GENOTYPE | 21 | 75% | 2% | 15 |
3 | PYRAZINAMIDE | 19 | 17% | 12% | 107 |
4 | INDUCED HEPATITIS | 19 | 27% | 7% | 62 |
5 | SHORT COURSE RIFAMPIN | 18 | 83% | 1% | 10 |
6 | PREVENTIVE THERAPY | 15 | 23% | 7% | 60 |
7 | DRUG INDUCED HEPATOTOXICITY | 14 | 29% | 5% | 42 |
8 | SOUTH INDIAN PATIENTS | 11 | 56% | 2% | 14 |
9 | TREATMENT COMPLETION | 11 | 36% | 3% | 24 |
10 | ISONIAZID ASSOCIATED HEPATITIS | 10 | 52% | 2% | 13 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Antituberculosis drug-induced hepatotoxicity: Concise up-to-date review | 2008 | 149 | 86 | 62% |
An official ATS statement: Hepatotoxicity of antituberculosis therapy | 2006 | 278 | 135 | 44% |
NAT2 polymorphisms and susceptibility to anti-tuberculosis drug-induced liver injury: a meta-analysis | 2012 | 19 | 36 | 69% |
Recent progress in genetic variation and risk of antituberculosis drug-induced liver injury | 2014 | 3 | 18 | 100% |
TOXIC HEPATITIS WITH ISONIAZID AND RIFAMPIN - A METAANALYSIS | 1991 | 224 | 16 | 75% |
Age-related risk of hepatotoxicity in the treatment of latent tuberculosis infection: a systematic review | 2010 | 32 | 41 | 73% |
Treatment of latent tuberculosis infection: An update | 2010 | 51 | 102 | 50% |
Antituberculosis drugs and hepatotoxicity | 2006 | 88 | 71 | 68% |
Treatment of Latent Tuberculosis Infection Preface | 2013 | 10 | 115 | 47% |
Adherence to treatment for latent tuberculosis infection: systematic review of studies in the US and Canada | 2008 | 63 | 85 | 55% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DRUG REASSESSMENT | 14 | 100% | 0.8% | 7 |
2 | CHARLES P FELTON TB | 5 | 50% | 0.8% | 7 |
3 | HOSP XERAL CIES VIGO | 2 | 67% | 0.2% | 2 |
4 | TB TREATMENT | 2 | 36% | 0.5% | 4 |
5 | TB CONTROL PREVENT | 1 | 12% | 1.4% | 12 |
6 | JAIL HLTH SERV | 1 | 31% | 0.5% | 4 |
7 | CATALAN HLTH ICS | 1 | 40% | 0.2% | 2 |
8 | AMBULATORY CARE COMMUNITY MED PMU | 1 | 50% | 0.1% | 1 |
9 | ANALISES CLINICAS | 1 | 50% | 0.1% | 1 |
10 | BC DIS CONTROL SOC | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000232030 | ANTI MYCOBACTERIAL DRUGS//CRESCENTIC MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS//INFECT IMMUN IMMUNOL |
2 | 0.0000204956 | SANIDAD SEGURIDAD SOCIAL LLEIDA//UNIDAD INVEST TB BARCELONA//DENVER METRO TB CONTROL PROGRAM |
3 | 0.0000158123 | MED PSYCHIAT DRUG ADDICT UNIT//ISONIAZID INTOXICATION//ZIPEPROL |
4 | 0.0000148179 | CHILDHOOD TUBERCULOSIS//DESMOND TUTU TB//TUBERCULOSIS IN CHILDREN |
5 | 0.0000129965 | ISONIAZID PREVENTIVE THERAPY//TB CONTROL PROGRAMME//TB HIV |
6 | 0.0000129866 | EARLY BACTERICIDAL ACTIVITY//DELAMANID//BEDAQUILINE |
7 | 0.0000127913 | EPIDEMIOLOGY OF TUBERCULOSIS//RENAL ALLOGRAFT RECIPIENT//TUBERCULOUS PERITONITIS |
8 | 0.0000123719 | DRUG INDUCED LIVER INJURY//HERB INDUCED LIVER INJURY//HYS LAW |
9 | 0.0000122711 | TUBERCULIN SKIN TEST//INTERFERON GAMMA RELEASE ASSAY//T SPOTTB |
10 | 0.0000101717 | INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE//DOTS//STOP TB |